Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates

分组1 - Zoetis reported quarterly earnings of $1.48 per share, exceeding the Zacks Consensus Estimate of $1.4 per share, and showing an increase from $1.4 per share a year ago, resulting in an earnings surprise of +5.85% [1] - The company achieved revenues of $2.39 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.92% and increasing from $2.32 billion year-over-year [2] - Zoetis has outperformed the S&P 500, with shares increasing by about 2.3% since the beginning of the year compared to the S&P 500's gain of 1.4% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.59 on revenues of $2.34 billion, and for the current fiscal year, it is $6.80 on revenues of $9.94 billion [7] - The Zacks Industry Rank indicates that the Medical - Drugs sector is in the bottom 43% of over 250 Zacks industries, suggesting potential challenges for stocks in this category [8]